SCHEMBL7035552

SCHEMBL7035552

COc1ccc(-c2c(-c3cccs3)[nH]c3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.56
PTGS1 P23219 1/20 0.55
PDE10A Q9Y233 1/20 0.54
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
MMP13 P45452 1/20 0.49
TUBB4A P04350 1/20 0.49
TUBB P07437 1/20 0.49
TUBA3C P0DPH7 1/20 0.49
TUBA1B P68363 1/20 0.49
TUBA4A P68366 1/20 0.49
TUBB4B P68371 1/20 0.49
TUBB3 Q13509 1/20 0.49
TUBB2A Q13885 1/20 0.49
TUBB8 Q3ZCM7 1/20 0.49
TUBA3E Q6PEY2 1/20 0.49
TUBA1A Q71U36 1/20 0.49
TUBA1C Q9BQE3 1/20 0.49
TUBB6 Q9BUF5 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28254287 0.89 PDE10A (0.57) PTGS2PTGS1PDE10AMMP2MMP9
Indoxole SCHEMBL29519430 0.82 PTGS2 (0.76) PTGS2PTGS1TUBB4ATUBBTUBA3C
Indoxole SCHEMBL42592 0.82 PTGS2 (0.76) PTGS2PTGS1TUBB4ATUBBTUBA3C
SCHEMBL7039033 0.82 ESR1 (0.67) PTGS2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL28253409 0.80 TUBB4A (0.48) PTGS2PTGS1PDE10AMMP2MMP9
SCHEMBL7039067 0.80 PTGS2 (0.72) PTGS2PTGS1TUBB4ATUBBTUBA3C
SCHEMBL7042910 0.80 PTGS2 (0.72) PTGS2PTGS1TUBB4ATUBBTUBA3C
SCHEMBL18160179 0.76 PTGS2 (0.67) PTGS2PTGS1TUBB4ATUBBTUBA3C
SCHEMBL7039642 0.76 ESR2 (0.77) PTGS2PTGS1TUBB4ATUBBTUBA3C
SCHEMBL27566954 0.75 PTGS2 (0.62) PTGS2PTGS1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030220377-A1 Indole compounds and their use as estrogen agonists/antagonists CHESWORTH RICHARD (US) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220377-A1 Indole compounds and their use as estrogen agonists/antagonists ESR1, GPER1, ESR2 PTGS2 735/4885PTGS1 617/4885PDE10A 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.